These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 28126414)
1. Recent progress in the discovery of natural inhibitors against human carboxylesterases. Wang DD; Zou LW; Jin Q; Hou J; Ge GB; Yang L Fitoterapia; 2017 Mar; 117():84-95. PubMed ID: 28126414 [TBL] [Abstract][Full Text] [Related]
2. Carboxylesterase Inhibitors: An Update. Zou LW; Jin Q; Wang DD; Qian QK; Hao DC; Ge GB; Yang L Curr Med Chem; 2018; 25(14):1627-1649. PubMed ID: 29210644 [TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Relationships of Pentacyclic Triterpenoids as Potent and Selective Inhibitors against Human Carboxylesterase 1. Zou LW; Dou TY; Wang P; Lei W; Weng ZM; Hou J; Wang DD; Fan YM; Zhang WD; Ge GB; Yang L Front Pharmacol; 2017; 8():435. PubMed ID: 28713276 [TBL] [Abstract][Full Text] [Related]
4. Characterization and structure-activity relationship studies of flavonoids as inhibitors against human carboxylesterase 2. Weng ZM; Ge GB; Dou TY; Wang P; Liu PK; Tian XH; Qiao N; Yu Y; Zou LW; Zhou Q; Zhang WD; Hou J Bioorg Chem; 2018 Apr; 77():320-329. PubMed ID: 29421708 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of human carboxylesterases by magnolol: Kinetic analyses and mechanism. Song YQ; Weng ZM; Dou TY; Finel M; Wang YQ; Ding LL; Jin Q; Wang DD; Fang SQ; Cao YF; Hou J; Ge GB Chem Biol Interact; 2019 Aug; 308():339-349. PubMed ID: 31170387 [TBL] [Abstract][Full Text] [Related]
6. Human carboxylesterases: a comprehensive review. Wang D; Zou L; Jin Q; Hou J; Ge G; Yang L Acta Pharm Sin B; 2018 Sep; 8(5):699-712. PubMed ID: 30245959 [TBL] [Abstract][Full Text] [Related]
7. Carboxylesterase inhibitors from clinically available medicines and their impact on drug metabolism. Song YQ; Jin Q; Wang DD; Hou J; Zou LW; Ge GB Chem Biol Interact; 2021 Aug; 345():109566. PubMed ID: 34174250 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2. Zou LW; Li YG; Wang P; Zhou K; Hou J; Jin Q; Hao DC; Ge GB; Yang L Eur J Med Chem; 2016 Apr; 112():280-288. PubMed ID: 26900660 [TBL] [Abstract][Full Text] [Related]
9. Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1. Wang YQ; Weng ZM; Dou TY; Hou J; Wang DD; Ding LL; Zou LW; Yu Y; Chen J; Tang H; Ge GB Int J Biol Macromol; 2018 Dec; 120(Pt B):1944-1954. PubMed ID: 30268757 [TBL] [Abstract][Full Text] [Related]
10. Human carboxylesterases and their role in xenobiotic and endobiotic metabolism. Ross MK; Crow JA J Biochem Mol Toxicol; 2007; 21(4):187-96. PubMed ID: 17936933 [TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide down-regulates carbolesterases 1 and 2 and reduces hydrolysis activity in vitro and in vivo via p38MAPK-NF-κB pathway. Mao Z; Li Y; Peng Y; Luan X; Gui H; Feng X; Hu G; Shen J; Yan B; Yang J Toxicol Lett; 2011 Mar; 201(3):213-20. PubMed ID: 21237253 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 alters the cellular responsiveness to clopidogrel, irinotecan, and oseltamivir by suppressing the expression of carboxylesterases HCE1 and HCE2. Yang J; Shi D; Yang D; Song X; Yan B Mol Pharmacol; 2007 Sep; 72(3):686-94. PubMed ID: 17537833 [TBL] [Abstract][Full Text] [Related]
13. Development of a novel system for estimating human intestinal absorption using Caco-2 cells in the absence of esterase activity. Ohura K; Sakamoto H; Ninomiya S; Imai T Drug Metab Dispos; 2010 Feb; 38(2):323-31. PubMed ID: 19923255 [TBL] [Abstract][Full Text] [Related]
14. Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin. Yang D; Pearce RE; Wang X; Gaedigk R; Wan YJ; Yan B Biochem Pharmacol; 2009 Jan; 77(2):238-47. PubMed ID: 18983829 [TBL] [Abstract][Full Text] [Related]
15. Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis. Harada T; Nakagawa Y; Wadkins RM; Potter PM; Wheelock CE Bioorg Med Chem; 2009 Jan; 17(1):149-64. PubMed ID: 19062296 [TBL] [Abstract][Full Text] [Related]
16. Construction and application of a high-content analysis for identifying human carboxylesterase 2 inhibitors in living cell system. Xue L; Qian X; Jin Q; Zhu Y; Wang X; Wang D; Ge G; Yang L Anal Bioanal Chem; 2020 Apr; 412(11):2645-2654. PubMed ID: 32123952 [TBL] [Abstract][Full Text] [Related]
17. The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Laizure SC; Herring V; Hu Z; Witbrodt K; Parker RB Pharmacotherapy; 2013 Feb; 33(2):210-22. PubMed ID: 23386599 [TBL] [Abstract][Full Text] [Related]
18. Bysspectin A, an unusual octaketide dimer and the precursor derivatives from the endophytic fungus Byssochlamys spectabilis IMM0002 and their biological activities. Wu YZ; Zhang HW; Sun ZH; Dai JG; Hu YC; Li R; Lin PC; Xia GY; Wang LY; Qiu BL; Zhang JF; Ge GB; Lin S Eur J Med Chem; 2018 Feb; 145():717-725. PubMed ID: 29353723 [TBL] [Abstract][Full Text] [Related]
19. [Design and development of fluorescent probe substrates for carboxylesterase 1 using BODIPY as the basic fluorophore]. Ding LL; Tian ZH; Hou J; Weng ZM; Cui JN; Yang L; Ge GB Yao Xue Xue Bao; 2017 Jan; 52(1):58-65. PubMed ID: 29911769 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors. Tsurkan LG; Hatfield MJ; Edwards CC; Hyatt JL; Potter PM Chem Biol Interact; 2013 Mar; 203(1):226-30. PubMed ID: 23123248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]